A study demonstrated that PRSS3 was ectopically expressed in metastatic tissues of PCa and identified PRSS3 as a promising therapeutic target for metastatic PCa (Hockla et al., 2012). This evidence concerns the gene PRSS3 and posterior cortical atrophy.